Data Collection, Clinical Care and Interventions in CCR, NCI

Launched by NATIONAL CANCER INSTITUTE (NCI) · Jun 17, 2009

Keywords

ClinConnect Summary

This is an observational study at the NIH Clinical Center where researchers collect information from people who are receiving standard cancer-related care through the National Cancer Institute (NCI). No experimental drugs or new treatments are given as part of this protocol. The main goal is to build a data repository by gathering information from people seen for consultations, treatment, or follow-up, including donors and individuals with certain genetic findings, to help future research.

People of a wide age range may be eligible, from newborns to adults up to about 120 years old, depending on the situation. In general, you might qualify if you are seeking a consultation from NCI/CCR, your care would be seriously affected if you had to leave the center, you have cancer or are at risk for cancer or HIV, you are donating cells, or you have a genetic finding that requires confirmation. You’ll receive standard care, including routine labs and imaging. Data from your care will be stored for ongoing use and may be shared with NIH researchers in the future, with permission from the study lead. The study is ongoing at the NIH Clinical Center in Bethesda, Maryland, sponsored by the National Cancer Institute.

Gender

ALL

Eligibility criteria

• * INCLUSION CRITERIA:
• • Individuals must be age 2 years or older if therapeutic interventions are required. Otherwise, there are no age restrictions beyond the neonatal period (4 weeks).
• * Individuals will be eligible if they meet one of the following criteria:
• • are seeking a consultation from NCI/CCR.
• • whose medical welfare will be seriously compromised by referral back to the community, such as rare/complex diseases in which community treatment is inadequate or adequate community resources are unavailable.
• • have cancer, HIV, or are at risk for cancer and/or HIV for whom cancer evaluation, treatment or management at the NCI is requested.
• • who will serve or have served as cellular therapy donors, for the treatment of a recipient of cellular therapy on an NCI trial.
• • are participants or biologic family members of deceased participants, where genetic testing is required or a clinically actionable germline pathogenic or likely pathogenic variant with medical implications was discovered by a research laboratory that requires CLIA confirmation. Note: In some cases, enrollment onto this study is also necessary when the prior study on which the involved participant was originally enrolled is closed and/or the participant is now off study.
• • The individual or their Legally Authorized Representative is able and willing to provide informed consent.
• EXCLUSION CRITERIA:
• • None